Swiss Medica, Inc.

Swiss Medica, Inc.

March 10, 2005 08:00 ET

Swiss Medica Launches Multi-Media Advertising Campaign to Support U.S. Sales of O24 Essential Oil Pain Neutralizer



OTC Bulletin Board SYMBOL: SWME

MARCH 10, 2005 - 08:00 ET

Swiss Medica Launches Multi-Media Advertising Campaign
to Support U.S. Sales of O24 Essential Oil Pain

TORONTO, ONTARIO--(CCNMatthews - March 10, 2005) - Swiss Medica
(OTCBB:SWME) is pleased to announce that the multi-media advertising
campaign to provide nationwide support for pharmacy chains selling the
O24 Essential Oil Pain Neutralizer has begun. This is a multi-phased
advertising campaign that will run through the end of 2005.

Print advertising commenced with the April issue of Prevention magazine,
to be followed by several advertisements in high-circulation women's and
senior's magazines. Broadcast advertising commences next week, initially
on network radio stations so that coverage reaches all major cities in
the continental U.S.

"This is an extensive and pervasive advertising campaign, using
previously tested marketing strategies, and is designed to provide full
support for current regional and national pharmacy chains selling O24,"
announced Tom Quinn, Vice President for U.S. Operations. "The print and
broadcast campaign will evolve in a series of stages with numerous
surprises along the way."

About Swiss Medica Inc.

Swiss Medica commercializes proprietary bioscience products that relieve
chronic ailments. We increase our market share through focused
distribution strategies in multiple sales channels. Swiss Medica's
mission is to be a world leader in the commercialization of life
enhancing bioscience products that improve quality of lives. Please
visit our websites at and

Swiss Medica's flagship product, the O24™ Essential Oil Pain
Neutralizer, holds US Patent #6,444,238B1. The O24™ pain relief
solution has been used, recommended and praised for its fast-acting and
long-lasting benefits by healthcare professionals in the United States,
Canada and in Europe. O24 is widely available throughout Canada in
leading pharmacies and natural food stores. It is currently sold in an
increasing number of pharmacies throughout the United States. Customers
can also visit, for ordering details and store locators
for the nearest pharmacy.

Forward-looking statements in this news release are made pursuant to the
"Safe Harbor" provisions of the United States Private Securities
Litigation Reform Act of 1995. Investors are cautioned that such
forward-looking statements involve risks and uncertainties, including,
without limitation, risks relating to the ability to close transactions
being contemplated, risks related to international sales and potential
foreign currency exchange fluctuations, continued acceptance of Swiss
Medica's products, increased levels of competition, technological
changes, dependence on intellectual property rights and other risks
detailed from time to time in Swiss Medica's periodic reports filed with
the United States Securities and Exchange Commission and other
regulatory authorities.


Contact Information

    Swiss Medica Inc.
    Investor Relations Contact:
    David Jones
    1 866 485 4243
    Blue Skye PR, Inc.
    Press Contact:
    Sky Wallen
    (813) 732-6869